NCT04797793 - A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

978

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

January 8, 2021

Study Completion Date

January 8, 2021

Conditions

Acne Vulgaris

Interventions

DRUG

Adapalene Gel 0.1%

The study medication will be self-applied topically on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days.

DRUG

Placebo Control

The study medication will be self-applied topically on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days.

DRUG

Differin® Gel (Adapalene 0.1%, Galderma)

The study medication will be self-applied topically on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days.

Trial Locations (1)

28217

Catawba Research, LLC, Charlotte